Related Experiment Video
Updated: Jun 24, 2026

05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Percutaneous aortic valve replacement using a W-model valved stent: a preliminary feasibility study in sheep
Yuan Bai1, Gang-Jun Zong, Yan-Yan Wang
1Department of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Chinese Medical Journal
|March 28, 2009
Summary
Percutaneous aortic valve replacement using a novel W-model valved stent in beating hearts is feasible. Further research is needed to confirm the safety and effectiveness of this innovative aortic valve treatment.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Interventional Cardiology
Background:
- Aortic valve stenosis necessitates advanced treatment options.
- Percutaneous aortic valve replacement (PAVR) shows promise but requires further clinical validation.
- A novel W-model valved stent was developed to address limitations in current PAVR devices.
Purpose of the Study:
- To evaluate the feasibility and safety of percutaneous implantation of a W-model valved stent.
- To assess the device's performance in the native aortic valve position in a preclinical model.
Main Methods:
- A self-expanding nitinol stent with a W-model configuration and porcine pericardium valves was implanted in six sheep.
- Catheter-based delivery via the right common iliac artery under fluoroscopic guidance.
- Post-procedure evaluation included angiography, ventriculography, and anatomical assessment.
Main Results:
- Successful aortic valve replacement in the beating heart was achieved in four out of six sheep.
- Procedure failure occurred in two sheep due to coronary orifice occlusion and severe aortic regurgitation.
- Anatomical evaluation revealed no damage to the aortic intima or coronary orifice obstruction.
Conclusions:
- Percutaneous aortic valve replacement with the W-model valved stent in a beating heart is technically possible.
- The study highlights the need for larger sample sizes and extended follow-up periods to fully ascertain safety and efficacy.
- Further investigation is essential to optimize this novel valved stent for clinical application.

